Skip to main content
EXOZYMES INC. logo

EXOZYMES INC. — Investor Relations & Filings

Ticker · EXOZ ISIN · US4618741098 US Manufacturing
Open in API
Filings indexed 95 across all filing types
Latest filing 2026-06-08 Share Issue/Capital Cha…
Country US United States of America
Listing US EXOZ

About EXOZYMES INC.

https://exozymes.com/

EXOZYMES INC. develops a proprietary, cell-free biomanufacturing platform utilizing 'exozymes'—advanced enzymes engineered with artificial intelligence to function efficiently outside of living cells. The technology transforms affordable and widely available feedstocks, such as sugar and biomass, into a diverse range of high-value, small-molecule chemicals. The company focuses on the scalable production of compounds for the nutraceutical, pharmaceutical, and biofuel markets. This approach provides a sustainable alternative to traditional petrochemical production and overcomes the scaling limitations of conventional cell-based synthetic biology, enabling the efficient manufacturing of high-purity ingredients.

Recent filings

Filing Released Lang Actions
424B5
Share Issue/Capital Change Classification · 87% confidence The document is a Form 424B5 prospectus supplement filed under Rule 424(b)(5) as part of a shelf registration statement for a securities offering. It details the terms of a new issuance of common stock and warrants by the company, including pricing, underwriting, and risk factors. This is not an earnings release, management report, or an announcement of a meeting or vote; rather, it is the official offering document for a share issuance. Under the classification schema, this best fits “Share Issue/Capital Change” (SHA).
2026-06-08 English
424B5
Capital/Financing Update Classification · 87% confidence The document is a Rule 424(b)(5) preliminary prospectus supplement and accompanying base prospectus for eXoZymes Inc., detailing the terms of a new equity and warrant offering (number of shares, warrant terms, underwriting arrangements, risk factors, use of proceeds, etc.). This is not an earnings release, financial report, or management presentation, but rather the formal securities offering document used to raise capital. Under the category definitions, this falls under Capital/Financing Update (CAP) as it provides comprehensive details of the company’s fundraising transaction.
2026-06-04 English
424B5
Capital/Financing Update Classification · 68% confidence The document is a preliminary prospectus supplement filed under Rule 424(b)(5) for a new offering of common stock and warrants, detailing pricing, underwriting arrangements, and terms of the offering. This is clearly a financing/ capital raising document rather than a regular financial report, management announcement, or proxy. It falls under the "Capital/Financing Update" category.
2026-05-29 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-14 English
8-K - EXOZYMES INC. (0002010788) (Filer)
Report Publication Announcement Classification · 90% confidence The document is an SEC Form 8-K current report (Item 8.01) that simply states an Investor Presentation is attached as an exhibit. The text does not contain the presentation itself, only the announcement that it is provided. It is also under 5,000 characters and uses language like “Attached is an Investor Presentation.” Under the “menu vs. meal” rule, this is a report publication announcement rather than the actual report or presentation, so it should be classified as RPA.
2026-05-07 English
8-K - EXOZYMES INC. (0002010788) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 10, 2026, by eXoZymes Inc. It includes an Item 8.01 Other Events section stating that an Investor Presentation is attached and provided to potential underwriters and offering participants for a proposed securities offering. The document does not contain the presentation itself but references it as an exhibit. The length is 3473 characters, which is relatively short and consistent with an announcement rather than a full report. The primary content is the announcement of the investor presentation related to financing activities. Therefore, this filing is best classified as a Capital/Financing Update (CAP).
2026-04-10 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.